539 related articles for article (PubMed ID: 37005366)
1. Association between antihypertensive drugs and hepatocellular carcinoma: A trans-ancestry and drug-target Mendelian randomization study.
Wang Z; Lu J; Hu J
Liver Int; 2023 Jun; 43(6):1320-1331. PubMed ID: 37005366
[TBL] [Abstract][Full Text] [Related]
2. Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations.
Fan B; Zhao JV
BMC Med; 2024 Jan; 22(1):6. PubMed ID: 38166843
[TBL] [Abstract][Full Text] [Related]
3. Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study.
Zhao JV; Liu F; Schooling CM; Li J; Gu D; Lu X
Diabetologia; 2022 Apr; 65(4):695-704. PubMed ID: 35080656
[TBL] [Abstract][Full Text] [Related]
4. Exploring the causal relationship between antihypertensive drugs and glioblastoma by combining drug target Mendelian randomization study, eQTL colocalization, and single-cell RNA sequencing.
Zhao S; Xie Y; Ding X; Zheng C; Chen J; Zhao N; Ji Y; Wang Q; Liu Y; Cheng C
Environ Toxicol; 2024 Jun; 39(6):3425-3433. PubMed ID: 38450887
[TBL] [Abstract][Full Text] [Related]
5. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
[TBL] [Abstract][Full Text] [Related]
6. Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study.
Ardissino M; Slob EAW; Rajasundaram S; Reddy RK; Woolf B; Girling J; Johnson MR; Ng FS; Gill D
BMC Med; 2022 Sep; 20(1):288. PubMed ID: 36064525
[TBL] [Abstract][Full Text] [Related]
7. The effects of blood pressure and antihypertensive drugs on heart failure: A Mendelian randomization study.
Li Y; Xiao W; Huang N; Zhuang Z; Zhang L; Wang W; Song Z; Zhao Y; Dong X; Xu M; Huang T
Nutr Metab Cardiovasc Dis; 2023 Jul; 33(7):1420-1428. PubMed ID: 37156668
[TBL] [Abstract][Full Text] [Related]
8. Genetically predicted blood pressure, antihypertensive drugs and risk of heart failure: a Mendelian randomization study.
Lian J; Shi X; Jia X; Fan J; Wang Y; Zhao Y; Yang Y
J Hypertens; 2023 Jan; 41(1):44-50. PubMed ID: 36129112
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic variants related to combined lipid-lowering and antihypertensive therapies with risk of cardiovascular disease: 2 × 2 factorial Mendelian randomization analyses.
Li Y; Liu H; Shen C; Li J; Liu F; Huang K; Gu D; Li Y; Lu X
BMC Med; 2024 May; 22(1):201. PubMed ID: 38764043
[TBL] [Abstract][Full Text] [Related]
10. Repurposing antihypertensive drugs for the prevention of Alzheimer's disease: a Mendelian randomization study.
Walker VM; Kehoe PG; Martin RM; Davies NM
Int J Epidemiol; 2020 Aug; 49(4):1132-1140. PubMed ID: 31335937
[TBL] [Abstract][Full Text] [Related]
11. Genetic evidence for a causal relationship between type 2 diabetes and peripheral artery disease in both Europeans and East Asians.
Xiu X; Zhang H; Xue A; Cooper DN; Yan L; Yang Y; Yang Y; Zhao H
BMC Med; 2022 Aug; 20(1):300. PubMed ID: 36042491
[TBL] [Abstract][Full Text] [Related]
12. Association of Antihypertensive Drug Target Genes With Psychiatric Disorders: A Mendelian Randomization Study.
Chauquet S; Zhu Z; O'Donovan MC; Walters JTR; Wray NR; Shah S
JAMA Psychiatry; 2021 Jun; 78(6):623-631. PubMed ID: 33688928
[TBL] [Abstract][Full Text] [Related]
13. Genetically determined blood pressure, antihypertensive medications, and risk of intracranial aneurysms and aneurysmal subarachnoid hemorrhage: A Mendelian randomization study.
Liu H; Zuo H; Johanna O; Zhao R; Yang P; Chen W; Li Q; Lin X; Zhou Y; Liu J
Eur Stroke J; 2024 Mar; 9(1):244-250. PubMed ID: 37800876
[TBL] [Abstract][Full Text] [Related]
14. Repurposing Antihypertensive Drugs for the Prevention of Glaucoma: A Mendelian Randomization Study.
Liu J; Li S; Hu Y; Qiu S
Transl Vis Sci Technol; 2022 Oct; 11(10):32. PubMed ID: 36264650
[TBL] [Abstract][Full Text] [Related]
15. Genetically determined blood pressure, antihypertensive drug classes, and frailty: A Mendelian randomization study.
Zhuang Z; Li Y; Zhao Y; Huang N; Wang W; Xiao W; Du J; Dong X; Song Z; Jia J; Liu Z; Clarke R; Qi L; Huang T
Aging Cell; 2024 May; ():e14173. PubMed ID: 38725159
[TBL] [Abstract][Full Text] [Related]
16. Utilizing genetics and proteomics to assess the role of antihypertensive drugs in human longevity and the underlying pathways: a Mendelian randomization study.
Fan B; Zhao JV
Eur Heart J Cardiovasc Pharmacother; 2024 May; ():. PubMed ID: 38769606
[TBL] [Abstract][Full Text] [Related]
17. Genetically Predicted Blood Pressure and Risk of Atrial Fibrillation.
Hyman MC; Levin MG; Gill D; Walker VM; Georgakis MK; Davies NM; Marchlinski FE; Damrauer SM
Hypertension; 2021 Feb; 77(2):376-382. PubMed ID: 33390040
[TBL] [Abstract][Full Text] [Related]
18. Lipids, Blood Pressure, and Diabetes Mellitus on Risk of Cardiovascular Diseases in East Asians: A Mendelian Randomization Study.
Ciofani JL; Han D; Allahwala UK; Woolf B; Gill D; Bhindi R
Am J Cardiol; 2023 Oct; 205():329-337. PubMed ID: 37633070
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis.
Wang K; Shi M; Huang C; Fan B; Luk AOY; Kong APS; Ma RCW; Chan JCN; Chow E
Cardiovasc Diabetol; 2022 Sep; 21(1):192. PubMed ID: 36151532
[TBL] [Abstract][Full Text] [Related]
20. Repurposing Antihypertensive and Statin Medications for Spinal Pain: A Mendelian Randomization Study.
Suri P; Elgaeva EE; Williams FMK; Freidin MB; Verzun DA; Tsepilov YA
Spine (Phila Pa 1976); 2023 Nov; 48(22):1568-1574. PubMed ID: 37539717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
